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Abstract
Introduction: To date, no novel treatment approach is available for optimum outcomes regarding 
refractory periodontitis. The aim of the present study was to assess the efficiency of photodynamic 
therapy (PDT) in treating patients diagnosed with refractory periodontitis and compare the clinical 
and biological outcomes of conventional periodontal treatment with or without adjunctive PDT in 
these patients, by assessing clinical parameters (plaque index [PI], gingival recession [GR], bleeding 
on probing [BOP], periodontal probing depth [PPD] and clinical attachment level [CAL]) as well as 
biological parameters (IL-1β) in the gingival crevicular fluid (GCF).
Methods: Sixteen patients within the age of 30 to 60 years, with a mean age of 40 years old, diagnosed 
with refractory periodontitis were included. In this split mouth design study, 2 quads (1 upper + 1 
lower) from the same patient were randomly treated with (scaling and root planing [SRP]+PDT) 
together. The other 2 quadrants (1 upper + 1 lower) were treated by SRP only and selected to serve 
as controls. Clinical parameters including PI, GR, BOP, PPD and CAL and biological parameters 
(IL-1β) in the GCF were measured at baseline, then at, 2 and 6 months after therapy.
Results: A statistically significant reduction in several clinical parameters as, BOP (P < 0.001), PI (P 
< 0.001), PPD (P < 0.001) and CAL (P < 0.001) in quadrant treated with SRP and adjunctive PDT 
when compared to control group treated with SRP alone was observed and both therapies showed 
non-statistically significant differences in the reduction of IL-1β level.
Conclusion: The inclusion of PDT as an adjunctive measure to nonsurgical conventional periodontal 
treatment seems to be a useful therapeutic measure in refractory periodontitis treatment.
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Introduction
Periodontitis is an inflammatory disease of the gingival 
and periodontal tissue, induced by pathogenic bacteria 
within the dental plaque biofilms, leading to clinical signs 
of inflammation and loss of the attachment apparatus 
supporting the teeth1,2 Periodontitis is one of the most 
common diseases of the oral cavity3 and is a multifactorial 
disease, several risk factors play a role in the disease 
etiology and modifies it’s course.4 
Up to now the critical objective of various periodontal 
treatment modalities has been to halt the progression of 
the disease and prevent its recurrence.
The conventional mechanical elimination of 
subgingival bacterial biofilms followed by an effective 
periodontal maintenance program are the cornerstone 
for controlling inflammatory periodontal disease, but this 
mechanical instrumentation of the root surface alone may 
fail to remove bacterial biofilm in some areas inaccessible 
to periodontal instruments, such as root depression and 
furcation.5 Also, periodontal mechanical debridement 
efficiency may decrease with increasing periodontal 
probing depths (PPDs) and with furcal involvement.6,7 
Thus, bacterial reservoirs could remain within the 
periodontal pockets on the root surface and promote 
recolonization which would affect periodontal healing 
and disease progression following treatment. 
Patients exhibiting refractory periodontitis, despite 
the therapeutic efforts show low responsiveness to 
periodontal therapy by dental professionals and continue 
to show destruction of periodontal tissue.8 The nature of 
refractory periodontitis has not been clearly understood 
yet. Various factors modulating host immune responses 
to bacterial challenge, including genetic factors, 
microbiological factors and other host-related factors 
(local or systemic) as local anatomic variations, smoking, 
diabetes, and other systemic diseases, were implicated in 
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the disease pathogenesis.9,10 
The adjunctive use of systemic antibiotic has been 
proven to be an effective measure in the management 
of refractory periodontitis. However, many drawbacks 
associated with their use have been known as resistance-
related phenomena, development of opportunistic 
infections, their unfavorable systemic side effects and 
the disagreements regarding their prescription.11,12 Such 
drawbacks necessitate alternative strategies to control 
bacterial biofilms and to treat periodontal diseases.13 
Photodynamic therapy (PDT) has been proposed as 
adjunctive treatment strategy to conventional mechanical 
therapy. This therapy utilizes singlet oxygen and free 
radicals, produced upon light – mediated activation of a 
photosensitizing agent to kill microbes.14 
PDT seems to be an attractive treatment modality, which 
may be useful during initial and maintenance therapy for 
the treatment of refractory periodontitis, especially for 
residual pocket treatment, as it is a noninvasive low-level 
therapy, localized, low-cost, quick and simple treatment 
approach with confirmed clinical safety.15
Antimicrobial effects of PDT not only kills the bacteria 
but may also lead to the detoxification of endotoxins, 
such as lipopolysaccharide, inhibiting their stimulatory 
effect on proinflammatory cytokines production by 
mononuclear cells, and decreasing their biological 
activity.16 
PDT was also expected to promote periodontal 
healing, due to its potential biomodulatory effects,15,17,18 
by inhibiting inflammatory mediators and host-derived 
cytokines, such as tumor necrosis factor-α, interleukin-
1β (IL-1β), and modulating host innate immunity, thus 
favoring cellular chemotaxis, promoting local vasodilation 
and collagen synthesis and angiogenesis.17,19,20 
Due to the intricacy and many mysterious elements 
for refractory periodontitis, management may not be 
conceivable in all cases. PDT may be a helpful modality in 
treating and managing refractory periodontitis.
The main objective of this study was to assess the 
efficiency of PDT as an adjunctive therapy to nonsurgical 
periodontal therapy in refractory periodontitis by 
assessing clinical parameters (plaque index [PI], gingival 
recession [GR], bleeding on probing [BOP], PPD and 
clinical attachment level [CAL]) as well as biological 
parameters (IL-1β) in the gingival crevicular fluid (GCF).
Methods
Patients, who have been diagnosed with refractory 
periodontitis according to patient’s records, were 
recruited from the Department of Periodontics, Faculty 
of Dentistry, and Jordan University of science and 
Technology, from October 2014 to December 2015. A 
diagnosis of refractory periodontitis only complies in 
patients who adequately comply with the recommended 
oral hygiene measures, attend regularly the scheduled 
periodontal maintenance appointments though continue 
to demonstrate a decline in their periodontal status, as 
evidenced by the clinical signs and symptoms.
The clinical characteristics of refractory periodontitis 
by Kornman21 were adopted to confirm diagnosis: 
1. Multiple sites display clinically noticeable disease 
advancement.
2. Disease progress is distinct to former severity i.e. 
progression occurs even in sites of slight or no prior 
disease.
3. Disease advancement is not stopped by traditional 
periodontal treatment and regular supportive care 
that focuses on reduction of tooth-adherent bacterial 
accumulations. 
Moreover, the diagnosis of “refractory” periodontitis 
was only made in patients who satisfactorily complied with 
the recommended oral hygiene measures and followed a 
regularly scheduled program of periodontal maintenance 
since diagnosis; this was confirmed by patients’ records.
Upon entering the study each patient completed a 
patient questionnaire and received a periodontal clinical 
examination. Patients who fulfilled the inclusion criteria 
for the study had been informed about the study and were 
invited to participate in the study which required patient’s 
commitment for a period of 6 months and each had been 
given a unique identifier.
The inclusion criteria included (1) aged 35 years or 
more; (2) having >12 natural teeth with a minimum 
of three in each quadrant, and (3) having refractory 
periodontitis.22 
Patients with the following criteria were excluded (1) 
current smokers; (2) pregnant females; (3) females on 
estrogen therapy; (4) those who had received systemic 
antibiotics or surgical periodontal treatment within 
the past 12 months and (5) those who had a history of 
poorly controlled diabetes, liver disease, malignancy, 
radiotherapy, or allergy to toluidine blue.
At the beginning, a total sample of 20 patients (9 males 
and 11 females) diagnosed with refractory periodontitis 
had met the inclusion/exclusion criteria. All subjects were 
examined on dental chairs in the periodontal clinics in the 
dental teaching center of Jordan University of science and 
technology using sterile dental mirror, dental explorer 
and periodontal probe to assess the oral condition. 
Periodontal examination was conducted by a blinded 
investigator who was not involved in the treatment of 
the patients. All periodontal clinical measurements 
were performed by one periodontist, allowing an intra-
experimental comparison of the values. Four patients 
with refractory periodontitis were examined at an interval 
of 48 hours. The intraclass correlation coefficients as a 
measure of intraexaminer reproducibility were 0.89 and 
0.90 for the mean PPD and CAL.
 At the start of every recall visit, the periodontist 
evaluated the gingival and periodontal tissues using a 
University of Michigan O’ Probe with William’s calibration. 
PPD, CAL, and GR were obtained at six sites of each tooth 
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(mesiobuccal, distobuccal, mesiolingual, distolingual and 
middle sites of the buccal and lingual sides). BOP was 
assessed at four sites of each tooth (mesial and distal sites 
of the buccal and lingual sides). Bleeding points were 
assessed 30 seconds after probing. Third molars were 
excluded from the examination. Clinical probing depths 
were measured to the nearest mm.
As shown in Figure 1, using a split-mouth design, 2 
quadrants were treated with scaling and root planing 
(SRP) (control group), while the other 2 quadrants 
were additionally treated with PDT (test group). All 
patients received a conventional periodontal treatment, 
comprising SRP of all periodontally involved teeth, both 
hand instruments (Gracey curettes) and a piezoelectric 
ultrasonic handpiece were employed, 2 quadrants (test 
group) were additionally treated with PDT. Therefore, 
after periodontal debridement, the quadrants were 
assigned to different groups. 
A total of 245 sites from 32 quadrants (16 upper and 
16 lower) were treated by SRP with PDT as adjunctive 
treatment and a total of 257 sites from 32 quadrants (16 
upper and 16 lower) were treated by SRP alone. Sites in 
contralateral quadrants had been separated by 1 tooth or 
more to avoid the photosensitizing agent flowing across 
the interdental papillae to the contra-lateral quadrant. 
Periodontal parameters were examined again after 2 
months and after 6 months of the treatment. Of eligible 
patients, one male and one female participant did not 
attend the follow-up examinations and were therefore 
excluded. Two other females were excluded also due to 
ingestion of systemic antibiotics during the follow-up 
examinations. 
A total of 16 subjects had successfully completed the 
study period of 6 months and were included in the data 
analyses. 
Results
In our clinical trial, PDT was performed with a PAD™ 
high level disinfection which is based on 2 components, 
the PAD™ solution (Orange dental, Denfotex Research 
Ltd, UK) and PAD Plus device (Orange dental, Denfotex 
Research Ltd, UK): a red LED light system of a specific 
wavelength (635 nm) to activate the PAD™ solution. 
This is the peak wavelength (635 nm) at which Toluidine 
Blue O (TBO) absorbs energy so maximum excitation 
and release of singlet oxygen is achieved. Photosensitizer 
was applied by placing the applicator at the bottom of the 
periodontal pocket and was continuously deposited in 
a coronal direction and left for 60 seconds. Afterwards, 
the PAD Plus was used with an 8.5-cm-long flexible 
fiber optic tip curved at an angle of 60° with a spot size 
0.06 cm in diameter for 60 seconds. This treatment 
approach was applied to all test sites. Laser was applied 
circumferentially at 6 sites per tooth. The application time 
of both the photosensitizer and laser light was monitored, 
to avoid phototoxic reactions. The calibration of the 
diode laser was performed according to the manufacturer 
instructions. 
Collection of GCF was done at baseline, 2 months and 
after 6 months for control and test sites. The site with the 
deepest pocket in each quadrant was chosen to take a 
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is based on 2 components, the PAD™ solution (Orange dental, Denfotex Research 
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2 quads (1 upper and 1 lower) for the same patient randomly 
treated with SRP+PDT while other 2 quads (1 upper and 1 lower) 
treated with SRP alone 
At least 2 or more independent sites 








At baseline, full mouth examination of all participants 
Oral cavity divided into 4 quads (split mouth) 
Figure 1. Procedure and Studied Groups.
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and a saliva ejector and gently air-dried after removal of 
the supragingival plaque from the interproximal surfaces. 
The GCF samples were collected with sterile paper 
strips (Periopaper, Oraflow Inc, Smithtown, NY, USA) 
carefully inserted into the crevice until mild resistance 
was felt and left in place for 30 seconds. Subsequently, 
the paper strips were placed into a sterile microtube vial 
and stored immediately at -20°C until analyzed. Samples 
visibly contaminated with blood were discarded. The 
levels of total IL-1β was measured using enzyme-linked 
immunosorbent assay (ELISA) kit (Platinum ELISA, 
eBioscience Inc, San Diego, CA, USA).
Results 
A total of 16 patients (8 males and 8 females) with 
refractory periodontitis had successfully completed 
the study period of 6 months. Patients aged between 30 
and 60 year, with a mean of 43.2 years. All subjects were 
Jordanian and none of them was smoker. 
The multivariate analysis using the general linear model 
(GLM) repeated measures procedures showed significant 
interaction between treatment and time effects on the 
studied parameters (P < 0.001) except for IL-1β (P = 
0.379). Table 1 shows the mean of clinical parameters of 
both treatment groups at baseline, 2 and 6 months. 
At the baseline, the 2 groups differed significantly in the 
mean PI only being higher in the SRP group (P = 0.019). 
Using the repeated analysis PDT as an adjunct treatment 
was superior to conventional treatment in patients 
diagnosed with refractory periodontitis in terms of clinical 
parameters including PI, BOP, PPD, and CAL. Except for 
IL-1β, there were remarkable and significant reduction 
in all clinical parameters after 2 months of the treatment 
in both treatment and control groups (P < 0.001). 
Thereafter, the mean of each clinical parameter increased 
significantly in both groups compared to the means at 2 
months. At 6 months, the means of clinical parameters 
remained significantly lower than the means at the 
baseline. At both 2 and 6 maintenance visits, the means 
of clinical parameters remained significantly lower in the 
test group than that in the control group. 
The study revealed superior results for PDT used as an 
adjunct to conventional treatment in patients diagnosed 
with refractory periodontitis in terms of clinical 
parameters. However PTD had no effects on the level of 
expression of cytokines (IL-1β). 
No adverse effects, such as discomfort, burning 
sensation, bleeding or pain related to the use of PDT, 
were reported by any of the participants.
Discussion
To the best of our knowledge, this is the first clinical trial 
that studied the effect of PDT on refractory periodontitis.
Several therapeutic modalities have been adopted for 
the treatment of refractory periodontitis, which includes 
scaling and root planning, surgical intervention and often 
systemic antibiotics administration. However, optimum 
results were hampered with the regrowth of bacterial 
biofilms leading to recurrence of inflammation and 
subsequent tissue destruction.
Table 1. The Change in the Means of Clinical Parameters Over Time for the Treatment (SRP+PDT) and Control (SRP) Groups
 






P value (0 vs. 2 
Months)
P value (0 vs. 6 
Months)
P value (2 vs. 6 
Months)
PI
SRP 1.26 (0.63) 0.67(0.47) 0.89(0.48) <0.001 <0.001 <0.001
SRP+PDT 1.13 (0.61) 0.38(0.49) 0.62(0.54) <0.001 <0.001 <0.001
P value (SRP vs. SRP+PDT) 0.019 <0.001 <0.001
BOP
SRP 0.99 (0.11) 0.61(0.49) 0.81(0.4) <0.001 <0.001 <0.001
SRP+PDT 0.96 (0.19) 0.03(0.18) 0.29(0.45) <0.001 <0.001 <0.001
P value (SRP vs. SRP+PDT) 0.066 <0.001 <0.001
PD
SRP 5.87 (1.2) 4.94(1.1) 5.4(1.17) <0.001 <0.001 <0.001
SRP+PDT 5.74 (1.16) 4.22(0.95) 4.62(0.9) <0.001 <0.001 <0.001
P value (SRP vs. SRP+PDT) 0.230 <0.001 <0.001
CAL 
SRP 6.75 (1.79) 5.9(1.77) 6.3(1.75) <0.001 <0.001 <0.001
SRP+PDT 6.65 (1.68) 5.27(1.5) 5.61(1.43) <0.001 <0.001 <0.001
P value (SRP vs. SRP+PDT) 0.512 <0.001 <0.001
IL-1β 
SRP 344.2 (277.4) 410.4 (174.2) 352.5 (204.3) 0.463 0.988 0.554
SRP+PDT 373.5 (215.0) 392.2 (139.8) 282.5 (159.2) 0.903 0.098 0.073
P value (SRP vs. SRP+PDT) 0.639 0.648 0.131
Abbreviations: PI, plaque index; GR, gingival recession; BOP, bleeding on probing; PPD, periodontal probing depth; CAL, clinical attachment level; 
IL-1β, interleukin-1β; PDT, photodynamic therapy; SRP, scaling and root planing; PD, Probing depth.
Journal of Lasers in Medical Sciences  Volume 10, Number 2, Spring 2019 143
                                                                                                      Photodynamic and Periodontitis
PDT was found to have a direct effect on extracellular 
molecules within the biofilm, such as polysaccharides, 
which were highly sensitive to singlet oxygen and 
susceptible to photo damage.23 Also, damage to DNA 
and plasma membrane proteins of periodontal pathogens 
have been demonstrated resulting in their deactivation, 
as Porphyromonas gingivalis or Fusobacterium 
nucleatum.24,25 PDT were found to be equally effective 
against antibiotic-resistant and antibiotic-susceptible 
bacteria, and upon repeated application of PDT, 
development of resistant strains has not been induced.26 
Some concerns regarding the clinical application of 
PDT were raised. One concern is the PDT’s potential 
photocytotoxicity to host cells. However, it has been 
demonstrated that PDT laser light dose required for 
bacterial killing is much lower than the toxic dose for 
keratinocytes and fibroblasts.27 Killing the entire flora 
leaving the host susceptible to opportunistic infections 
were another concern, which were managed by the 
introduction of selective photosensitizers, that selectively 
stain and kill the targeted pathogenic bacteria without 
affecting the surrounding periodontal tissues adversely.28,29 
In the present study, PI, BOP, PPD and CAL improved 
significantly in the sites treated with a combination of 
SRP and PDT from baseline to the final examination 
compared to SRP alone. 
Our results are consistent with what was reported by a 
study showing a significant decrease in the mean value 
of BOP and gain in the mean CAL from baseline, at six 
weeks and at 12 weeks compared to SRP alone on patients 
with moderate to advanced periodontal disease.30 This 
was supported by another study as well, adjunctive PDT 
was not only superior to SRP in terms of improvements in 
PD and CAL, but also in BOP.31 
In our study BOP was reduced in both groups. The 
decrease in BOP incidence in the present study in 
both test and control sites reflects the decrease in the 
periodontal inflammation, since the BOP index is a 
predictor of the progression of periodontal disease. These 
results were similar to a study that found improvement in 
full mouth bleeding score (FMBS) with adjunctive PDT.32 
Improvement only in bleeding scores could be attributed 
to photobiomodulation, as light can reduce inflammation 
and inflammatory cell infiltration, decrease the formation 
of abnormal blood vessels and bleeding, and maintains 
healthy blood vessels by the accelerating of collagen 
synthesis and organization.33,34 
The data out on PDT and periodontitis is not conclusive 
as a published systematic review/meta-analysis, 
concluded that using PDT as an adjunct or alternative to 
SRP did not add clinically significant benefits.35 A study 
stated that adjunctive PDT did not provide any additional 
benefits clinically or biologically.36 But all agreed that 
some benefits can be achieved by PDT, such as it is a 
noninvasive modality with minimal risk of thermal injury 
preventing damage to adjacent hard and soft periodontal 
tissue, reduced tendency to develop bacterial resistance, 
elimination of microorganisms in sites that might be 
inaccessible to selectivity in its effect, technical simplicity 
with rapid and painless application.
In this study, a significant reduction of the mean PI for 
(SRP) and (SRP+PDT) groups was noticed at the recall 
visits compared with the baseline measurement. The 
significant reduction of plaque was due to the thorough 
SRP performed at the first visit for both test and control 
sites and oral hygiene instructions. Our findings also 
showed significant reduction in mean values for PI in the 
test sites at 2 and 6 months postoperatively in comparison 
with the control sites. This is generally consistent with the 
results of previous studies.37 
Our findings for IL-1β levels analysis are consistent 
with the results of other investigations, which revealed 
that adjunctive PDT did not result in any significant 
changes in the levels of the inflammatory marker IL-1β.38
Thus, by adding adjunctive photodynamic treatment 
to conventional mechanical and chemical approaches, 
it might be possible to improve nonsurgical periodontal 
therapy approach. However, Further more detailed, 
controlled clinical, microbiological, and biochemical 
research and meta-analysis is necessary to determine 
the effectiveness of PDT in the treatment of refractory 
periodontitis. 
Few limitations have been observed in the study. The 
study was done for a short duration with a small sample 
size and confined to bilateral teeth exhibiting similar 
disease pattern. No microbiological sampling and analysis 
were carried on.
Within the limitation of this study, it is concluded 
that the PDT as an adjunct to SRP was superior to 
conventional treatment in patients diagnosed with 
refractory periodontitis in terms of clinical parameters. 
Results showed significant clinical improvement in 
terms of CAL gain, PI reduction, PD reduction and 
BOP reduction. Therefore, PDT adjunctive treatment 
may provide a more favorable healing environment and 
improve the periodontal clinical parameters.
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